Skip to content

Drug interactions

Fedratinib + Medroxyprogesterone

Severity: Minor

Fedratinib and Medroxyprogesterone: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib is a moderate CYP3A4 inhibitor and may raise exposure to medroxyprogesterone, which is partly cleared by CYP3A4. Increased progestogenic effects or adverse reactions are possible, though the clinical impact is not well characterized.

What this interaction means in plain words

Fedratinib and Medroxyprogesterone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fedratinib belongs to Oncology; Medroxyprogesterone belongs to Endocrine.

Evidence level: Low

Why it happens

Inhibition of CYP3A4-mediated metabolism of medroxyprogesterone by fedratinib.

What to do

No routine dose change is needed; watch for progestogenic adverse effects such as bleeding changes, fluid retention or mood changes. Review the need for the progestin if adverse effects emerge.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fedratinib and Medroxyprogesterone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fedratinib with Medroxyprogesterone?

MediHelp rates the interaction as minor. Fedratinib and Medroxyprogesterone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fedratinib is a moderate CYP3A4 inhibitor and may raise exposure to medroxyprogesterone, which is partly cleared by CYP3A4. Increased progestogenic effects or adverse reactions are possible, though the clinical impact is not well characterized.

How serious is the interaction between Fedratinib and Medroxyprogesterone?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine dose change is needed; watch for progestogenic adverse effects such as bleeding changes, fluid retention or mood changes. Review the need for the progestin if adverse effects emerge.

What other medicines interact with Medroxyprogesterone?

MediHelp also lists interactions of Medroxyprogesterone with, for example, Bosentan, Brigatinib, Eslicarbazepine. The full list is on the Medroxyprogesterone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in